Jessie X. Fan, Deanna L. Sharpe and Goog-Soog Hong, “Health Care and Prescription Drug Spending by Seniors,” Monthly Labor Review, Vol. 126, No. 3, pages 16-26, March 2003.

Teresa B.Gibson et al., “Cost-Sharing for Prescription Drugs,” Journal of the American Medical Association, Vol. 285, pages 2328-29, 2001.

Sherry A. Glied and Dahlia K. Remler, “What Every Public Finance Economist Needs to Know about Health Economics: Recent Advances and Unresolved Questions,” National Tax Journal, Vol. 55, pages 771-88, 2002.

R.E. Johnson et al., “The Impact of Increasing Patient Prescription Drug Cost Sharing on Therapeutic Classes of Drugs Received and on the Health Status of Elderly HMO Members,” Health Services Research, Vol. 32, No. 1, pages 103-22, April 1997.

A. Leibowitz, Willard G. Manning Jr. and Joseph P.Newhouse, “The Demand For Prescription Drugs as a Function of Cost-Sharing,” Rand Note, N-2278-HHS, October 1985.

Bernie O’Brien, “The Effect of Patient Charges on the Utilization of Prescription Medicines,” Journal of Health Economics, Vol. 8, No. 1, pages 109-32, March 1989.

John A. Poisal, “Misreporting of Drug Expenditures in the Medicare Current Beneficiary Survey,” Working Paper, Office of Research, Development, and Information, Centers for Medicare and Medicaid Services, 2003.

John A. Poisal, Lauren A. Murray, George S. Chulis and Barbara S. Cooper, “Prescription Drug Coverage and Spending for Medicare Beneficiaries,” Health Care Financing Review, Vol. 20, No. 3, pages 15-27, Spring 1999.

Alan T. Sorensen, “Equilibrium Price Dispersion in Retail Markets for Prescription Drugs,” Journal of Political Economy, Vol. 108, No. 4, pages 833-50, 2000.

A. Street, A. Jones and A. Furuta, “Cost-sharing and Pharmaceutical Utilization and Expenditure in Russia,” Journal of Health Economics, Vol. 18, No. 4, pages 459-72, 1999.

U.S. Department of Health and Human Services, Report to the President: Prescription Drug Coverage, Spending, Utilization, and Prices, April 2000.

U.S. Department of Health and Human Services, The Effects of H.R. 2473 on Prescription Drug Costs for Medicare Beneficiaries, June 24, 2003. H. White, “A Heteroskedasticity-Consistent Covariance Matrix Estimator and a Direct Test for Heteroskedasticity,” Econometrica, Vol. 48, pages 817-38, 1980.